Browsing Toxins
Displaying toxin 1326 - 1350 of 3678 in total
T3DB ID | Name CAS Number | Formula Weight | Structure | Type | Mechanism of Toxicity |
---|---|---|---|---|---|
T3D1605 | Silver fulminate 5610-59-3 | CAgNO 149.885 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1606 | Silver hexafluorophosphate 26042-63-7 | AgF6P 252.832 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1607 | Silver iodate 7783-97-3 | AgIO3 282.771 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1608 | Silver iodide 7783-96-2 | AgI 234.773 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1609 | Silver molybdate 13765-74-4 | Ag2MoO4 375.670 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1610 | Silver nitrate 7761-88-8 | AgNO3 169.873 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 26 | |
T3D1611 | Silver oxalate 533-51-7 | C2Ag2O4 303.755 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1612 | Silver oxide 20667-12-3 | Ag2O 231.736 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1613 | Silver perchlorate 7783-93-9 | AgClO4 207.319 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1615 | Silver subfluoride 1302-01-8 | Ag2F 234.735 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1616 | Silver sulfate 10294-26-5 | Ag2H2O4S 313.815 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1617 | Silver sulfide 21548-73-2 | AgS 139.933 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1618 | Silver telluride 12002-99-2 | Ag2Te 343.300 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1619 | Silver tetrafluoroborate 14104-20-2 | AgBF4 194.673 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1620 | Silver trifluoromethanesulfonate 1493-13-6 | CAgF3O3S 256.937 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1621 | Silver(II) fluoride 7775-41-9 | AgF2 145.865 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1622 | Silver(I,III) oxide 1301-96-8 | AgO 123.868 g/mol |
| Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disr...more Number of Targets: 17 | |
T3D1624 | Vanadium carbide 12070-10-9 | CH4V 66.984 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 | |
T3D1625 | Vanadium carbonyl 20644-87-5 | C6O6V 219.002 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 | |
T3D1626 | Vanadium nitride 24646-85-3 | NV 64.948 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 | |
T3D1627 | Vanadium oxytrichloride 7727-18-6 | Cl3OV 173.300 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 | |
T3D1628 | Vanadium tetrachloride 7632-51-1 | Cl4V 192.754 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 | |
T3D1629 | Vanadium(II) chloride 10580-52-6 | Cl2V 121.848 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 | |
T3D1630 | Vanadium(II) oxide 12035-98-2 | OV 66.941 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 | |
T3D1631 | Vanadium(III) chloride 7718-98-1 | Cl3V 157.301 g/mol |
| Vanadium damages alveolar macrophages by decreasing the macrophage membrane integrity, thus impairing the cells' phagocytotic ability and viability. The pentavalent fo...more Number of Targets: 47 |